Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIBNASDAQ:BISNASDAQ:CHNANASDAQ:FTXH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$47.17-1.7%$43.54$33.78▼$69.56$51.89M1.6311,531 shs2,149 shsBISProShares UltraShort Nasdaq Biotechnology$17.28+1.5%$19.32$14.05▼$25.87$2.94M-1.4111,953 shs12,656 shsCHNALoncar China Biopharma ETF$13.53$13.95$13.35▼$22.89$10.56M0.95538 shs9 shsFTXHFirst Trust Nasdaq Pharmaceuticals ETF$26.10-1.1%$25.13$23.29▼$29.72$14.36M0.75,739 shs1,740 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology-1.71%+0.90%+18.40%-11.29%-21.00%BISProShares UltraShort Nasdaq Biotechnology+1.53%-1.65%-16.88%+0.64%+2.98%CHNALoncar China Biopharma ETF0.00%0.00%0.00%0.00%0.00%FTXHFirst Trust Nasdaq Pharmaceuticals ETF-1.10%+0.65%+7.63%-6.69%-3.97%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/ABISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/ACHNALoncar China Biopharma ETFN/AN/AN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.75Moderate Buy$47.17N/ABISProShares UltraShort Nasdaq Biotechnology 0.00N/AN/AN/ACHNALoncar China Biopharma ETF 0.00N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.59Moderate Buy$26.10N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/ABISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/ACHNALoncar China Biopharma ETFN/AN/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68∞N/AN/AN/AN/AN/ABISProShares UltraShort Nasdaq BiotechnologyN/AN/A0.00∞N/AN/AN/AN/AN/ACHNALoncar China Biopharma ETFN/AN/A0.00∞N/AN/AN/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A16.72∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.941.99%N/AN/AN/ABISProShares UltraShort Nasdaq Biotechnology$0.653.76%N/AN/AN/ACHNALoncar China Biopharma ETF$0.060.44%N/AN/AN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.481.84%N/AN/AN/ALatest CHNA, BIS, FTXH, and BIB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/25/2025BIBProShares Ultra Nasdaq BiotechnologyQuarterly$0.13091.03%3/26/20253/26/20254/1/20253/25/2025BISProShares UltraShort Nasdaq BiotechnologyQuarterly$0.13252.99%3/26/20253/26/20254/1/20253/26/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.09921.45%3/27/20253/27/20253/31/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/ABISProShares UltraShort Nasdaq BiotechnologyN/ACHNALoncar China Biopharma ETFN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AInsider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/ABISProShares UltraShort Nasdaq BiotechnologyN/ACHNALoncar China Biopharma ETFN/AFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A1.10 millionN/AOptionableBISProShares UltraShort Nasdaq BiotechnologyN/A170,000N/AOptionableCHNALoncar China Biopharma ETF147,000780,814N/ANot OptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000550,000N/AOptionableCHNA, BIS, FTXH, and BIB HeadlinesRecent News About These CompaniesA Look at Pharma ETFs After Strong Q1 EarningsMay 8, 2025 | zacks.comFirst Trust Nasdaq BuyWrite Income ETF declares $0.207 dividendJanuary 22, 2025 | msn.comPharma ETFs in Focus Post Solid Q2 EarningsAugust 14, 2024 | zacks.comA Look at Pharma ETFs Post Q1 EarningsMay 7, 2024 | zacks.comJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in FocusApril 17, 2024 | zacks.com3 Health Care ETFs You'll Want to Own When the Market RecoversAugust 3, 2022 | stocknews.comSurprising Analyst 12-Month Target For FTXHMay 25, 2022 | nasdaq.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488March 25, 2022 | seekingalpha.comSolid Q4 Earnings Fail to Impress Pharma ETFsFebruary 22, 2022 | nasdaq.comWave of Solid Q3 Earnings Push Pharma ETFs HigherNovember 9, 2021 | nasdaq.com4 ETF Strategies to Follow Warren Buffett's VisionAugust 19, 2021 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCHNA, BIS, FTXH, and BIB Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$47.17 -0.82 (-1.71%) Closing price 06/13/2025 03:55 PM EasternExtended Trading$46.48 -0.69 (-1.47%) As of 06/13/2025 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.ProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS$17.29 +0.27 (+1.59%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Loncar China Biopharma ETF NASDAQ:CHNAThe Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$26.10 -0.29 (-1.10%) Closing price 06/13/2025 03:53 PM EasternExtended Trading$26.10 +0.00 (+0.02%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
